A Phase 2b, Multi-Site, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Tofacitinib (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 01 Dec 2014 Status changed from active, no longer recruiting to completed ClinicalTrials.gov record.
- 03 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.